U.S.-Azerbaijan Open Skies Agreement Enters Into Force
Monday, July 29, 2013
Drug Safety and Availability FDA Drug Safety Communication: FDA approves label changes for antimalarial drug mefloquine hydrochloride due to risk of serious psychiatric and nerve side effects
